Showing results 8 to 11 of 11
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2019 | 2 | |||
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD-L1 Journal:Hepatology Communications | 2021 | |||
2014 | 115 | |||
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses Journal:International Journal of Hepatology | 29-Nov-2022 |